Life Sciences Innovation has a dramatic impact on the life of billions of people. It is our opinion, that they will significantly improve global health and wellness and enable mankind to cope with the challenges of modern health care as well as the demographic developments of the near future. Key players of today concerning Life Sciences Innovation are small and medium-sized enterprises (SME), as most of the innovation within the industry is coming through them.
LAB-B’s mission is to accelerate innovation and time-to-market by providing strategic advice and financial support to pipeline-projects. Through various financing models, ranging from federal grants to private financing to promote Spin-Outs and Start-Ups, we help bringing ideas and technology faster from the lab to the market.
Our goal is to create value and improve health globally by accelerating the adoption of these technologies that empower consumers to better manage chronic conditions, preempt disease and improve the lives of the elderly and under-served populations around the world.
Making the process as efficient and seamless as possible helps to assure that exciting discoveries and technologies from our partner’s labs don’t get lost in translation and find their way to the patients who need them.
By collaborating with corporations, LAB-B is able to move forward innovation at every stage of the pipeline — from earliest ideas to products ready for clinical trials — with the companies who have a track record of delivering results to patients around the world.
Those Life Sciences Companies include companies in the fields of biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, cosmeceuticals, medical devices, and others that dedicate their efforts to research, development, and commercialization of products to improve people’s lives.
LAB-B supports those visionary companies, innovative organizations and dedicated people, who are passionate about improving our lives and changing the world.